blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0781753

EP0781753 - Enantiometric resolution of 4-(3,4-dichlorophenyl)-3, 4-dihydro-1(2H)-naphthalenone [Right-click to bookmark this link]
Former [1997/27]Enantiometric resolution of 4-(3,4-dichlorophenyl)-3, 4-dihydro-1 (2H)-naphthalenone
[1999/13]
StatusNo opposition filed within time limit
Status updated on  04.02.2000
Database last updated on 12.10.2024
Most recent event   Tooltip04.02.2000No opposition filed within time limitpublished on 22.03.2000 [2000/12]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [1997/27]For all designated states
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / Brose, Daniel J.
64234 Tumalo Rim Drive
Bend, Oregon / US
02 / Lorenz, Douglas A.
1164 NE Viking Court
Bend, Oregon / US
[1997/27]
Representative(s)Ruddock, Keith Stephen, et al
Pfizer
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
[N/P]
Former [1997/27]Ruddock, Keith Stephen, et al
Pfizer Limited, European Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date96120170.416.03.1994
[1997/27]
Priority number, dateUS1993003680925.03.1993         Original published format: US 36809
[1997/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0781753
Date:02.07.1997
Language:EN
[1997/27]
Type: B1 Patent specification 
No.:EP0781753
Date:31.03.1999
Language:EN
[1999/13]
Search report(s)(Supplementary) European search report - dispatched on:EP23.04.1997
ClassificationIPC:C07C49/697, C07C45/78
[1997/27]
CPC:
C07C49/697 (EP,US); C07B57/00 (EP,US); C07C45/78 (EP,US);
C07C45/79 (EP,US); C07C45/85 (EP,US)
C-Set:
C07C45/78, C07C49/697 (EP,US);
C07C45/79, C07C49/697 (US,EP);
C07C45/85, C07C49/697 (US,EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/27]
TitleGerman:Enantiomere Resolution von 4-(3,4-Dichlorphenyl)-3,4-Dihydro-1(2H)-Naphthalenon[1999/13]
English:Enantiometric resolution of 4-(3,4-dichlorophenyl)-3, 4-dihydro-1(2H)-naphthalenone[1999/13]
French:Résolution énantiomère de 4-(3,4-dichlorophényl)-3,4-dihydro-1(2H)-naphtalénone[1999/13]
Former [1997/27]Enantiomere Resolution von 4-(3,4-Dichlorphenyl)-3,4-Dihydro-1 (2H)-Naphthalenon
Former [1997/27]Enantiometric resolution of 4-(3,4-dichlorophenyl)-3, 4-dihydro-1 (2H)-naphthalenone
Former [1997/27]Résolution énantiomère de 4-(3,4-dichlorophényl)-3,4-dihydro-1 (2H)-naphtalénone
Examination procedure16.12.1996Examination requested  [1997/27]
28.04.1998Despatch of communication of intention to grant (Approval: Yes)
01.09.1998Communication of intention to grant the patent
09.11.1998Fee for grant paid
09.11.1998Fee for publishing/printing paid
Parent application(s)   TooltipEP94301884.6  / EP0616996
Opposition(s)06.01.2000No opposition filed within time limit [2000/12]
Fees paidRenewal fee
16.12.1996Renewal fee patent year 03
16.12.1996Renewal fee patent year 04
03.01.1998Renewal fee patent year 05
29.12.1998Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0186133  (DAICEL CHEM [JP]) [A] 1* page 6; claim 1 *
by applicantUS4536518
    - JIN ET AL., CHIRALITY., (1989), vol. 137
    - BENSCHOP ET AL., CHEMICAL COMMUNICATIONS., (1970), pages 1431 - 1432
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.